Bel Fuse Inc. (BELFB)

G1 Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	59.28	68.25	89.37	70.27	61.76	84.94
Short-Term Investments	-	0.95	37.55	-	-	-
Cash & Short-Term Investments	59.28	69.2	126.92	70.27	61.76	84.94
Cash Growth	-59.64%	-45.48%	80.63%	13.78%	-27.29%	17.50%
Receivables	127.64	116.37	96.92	125.52	115.41	85.51
Inventory	164.65	161.37	136.54	172.47	139.38	100.13
Other Current Assets	27.05	26.59	21.1	13.16	12.47	9.64
Total Current Assets	378.62	373.53	381.48	381.41	329.02	280.22
Property, Plant & Equipment	72.63	73	57.01	58.38	59.46	48.72
Long-Term Investments	12.02	12	14.24	5.54	-	-
Goodwill	211.29	208.04	26.64	25.1	26.65	23.97
Other Intangible Assets	225.01	231.95	49.39	54.11	61	65.79
Long-Term Deferred Tax Assets	15.87	16.43	11.55	7.28	4.46	5.71
Other Long-Term Assets	31.44	31.91	29.16	28.64	31.26	29.47
Total Assets	950.58	949.79	571.63	560.47	511.85	453.87
Accounts Payable	53.69	49.18	40.44	64.59	65.96	39.77
Accrued Expenses	38.6	45.65	47.62	33.94	31.16	27.47
Current Portion of Long-Term Debt	-	-	-	-	-	5.29
Current Portion of Leases	8.69	8.33	6.84	6.32	7.24	6.79
Current Unearned Revenue	-	6.12	3.05	8.85	4.45	2.08
Other Current Liabilities	23.11	18.79	12.67	22.61	3.2	6.14
Total Current Liabilities	124.08	128.07	110.61	136.3	112.01	87.54
Long-Term Debt	253.27	292.5	60	95	112.62	110.29
Long-Term Leases	16.39	18.82	15.75	17.35	16.32	8.85
Long-Term Deferred Tax Liabilities	27.91	28.92	1.46	1.26	1.49	1.03
Other Long-Term Liabilities	24.64	21.9	23.38	29.69	36.76	35.73
Total Liabilities	464.87	508.63	231.07	298.12	303.1	268.07
Common Stock	1.27	1.26	1.28	1.28	1.25	1.24
Additional Paid-In Capital	34.4	31.51	44.26	40.77	38.42	36.14
Retained Earnings	388.04	345.03	307.51	237.19	187.94	166.49
Treasury Stock	-	-	-0.45	-0.35	-	-
Comprehensive Income & Other	-18.96	-17.23	-12.04	-16.55	-18.86	-18.06
Total Common Equity	404.74	360.58	340.56	262.35	208.74	185.8
Minority Interest	80.97	80.59	-	-	-	-
Shareholders' Equity	485.71	441.16	340.56	262.35	208.74	185.8
Total Liabilities & Equity	950.58	949.79	571.63	560.47	511.85	453.87
Total Debt	278.35	319.64	82.59	118.67	136.18	131.22
Net Cash (Debt)	-219.06	-250.44	44.33	-48.4	-74.42	-46.28
Net Cash Per Share	-17.41	-19.85	3.47	-3.86	-6.00	-3.75
Filing Date Shares Outstanding	12.66	12.54	12.76	12.78	12.52	12.35
Total Common Shares Outstanding	12.66	12.54	12.76	12.78	12.52	12.35
Working Capital	254.53	245.46	270.87	245.1	217	192.68
Book Value Per Share	31.96	28.75	26.69	20.52	16.67	15.04
Tangible Book Value	-31.55	-79.41	264.53	183.14	121.1	96.04
Tangible Book Value Per Share	-2.49	-6.33	20.73	14.33	9.67	7.77
Land	0.13	0.12	0.35	1.1	1.11	1.12
Buildings	16.64	19.39	15.29	21.53	20.92	19.92
Machinery	103.26	99.75	98.53	118.36	120.96	124.11
Construction In Progress	4.75	5.24	1.57	4.24	5.08	1.6
Order Backlog	-	381.6	-	-	-	-

Updated Jul 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q